Exploring PRM-A as a novel glycan-targeted therapy for SARS-CoV-2 inhibition Post author: Post published: July 4, 2024 Post category:uncategorized HIV, Ebola and most recently, COVID-19 viruses have had an enormous impact on our societies world-wide. You Might Also Like 7 Reasons You’re Not Hitting Your A1C Goal September 5, 2024 UCLA researcher receives grant for advanced osteosarcoma immunotherapy June 22, 2026 Better maternal diet boosts brain growth and IQ in kids November 27, 2024